Frontiers in Cellular and Infection Microbiology (Feb 2023)

Interactions between microbiota and cervical epithelial, immune, and mucus barrier

  • Mengting Dong,
  • Mengting Dong,
  • Yalan Dong,
  • Yalan Dong,
  • Junyi Bai,
  • Junyi Bai,
  • Huanrong Li,
  • Huanrong Li,
  • Xiaotong Ma,
  • Xiaotong Ma,
  • Bijun Li,
  • Bijun Li,
  • Chen Wang,
  • Chen Wang,
  • Huiyang Li,
  • Huiyang Li,
  • Wenhui Qi,
  • Wenhui Qi,
  • Yingmei Wang,
  • Yingmei Wang,
  • Aiping Fan,
  • Aiping Fan,
  • Cha Han,
  • Cha Han,
  • Fengxia Xue,
  • Fengxia Xue

DOI
https://doi.org/10.3389/fcimb.2023.1124591
Journal volume & issue
Vol. 13

Abstract

Read online

The female reproductive tract harbours hundreds of bacterial species and produces numerous metabolites. The uterine cervix is located between the upper and lower parts of the female genital tract. It allows sperm and birth passage and hinders the upward movement of microorganisms into a relatively sterile uterus. It is also the predicted site for sexually transmitted infection (STI), such as Chlamydia, human papilloma virus (HPV), and human immunodeficiency virus (HIV). The healthy cervicovaginal microbiota maintains cervical epithelial barrier integrity and modulates the mucosal immune system. Perturbations of the microbiota composition accompany changes in microbial metabolites that induce local inflammation, damage the cervical epithelial and immune barrier, and increase susceptibility to STI infection and relative disease progression. This review examined the intimate interactions between the cervicovaginal microbiota, relative metabolites, and the cervical epithelial-, immune-, and mucus barrier, and the potent effect of the host-microbiota interaction on specific STI infection. An improved understanding of cervicovaginal microbiota regulation on cervical microenvironment homeostasis might promote advances in diagnostic and therapeutic approaches for various STI diseases.

Keywords